Abstract: The disclosure provides for cleaning three-dimensional (3D) components printed in a powder bed from adhering powder particles. The 3D-printed components are cleaned with a negative pressure-induced volumetric flow. The 3D-printed components are first removed from the powder bed after their manufacture, then positioned on a feed device and moved together with the feed device into a pressure-tight sealable chamber. In the interior of the chamber negative pressure is subsequently built up and a fluid volumetric flow is applied to the 3D-printed component to be cleaned which results in the powder particles being detached from the 3D-printed component. The powder particles are removed from the sealed chamber in a pressure tight manner via at least one channel conduit which is subjected to negative pressure and are fed to a separation device. The chamber is subsequently released of pressure and then opened for removal of the cleaned 3D-printed component.

Abstract: The invention relates autonomous VH domains (aVH) with cysteines in positions 52a and 71 or in positions 33 and 52 in order to stabilize the autonomous VH domains. Said cysteines are capable of forming a disulfide bond and/or form a disulfide bond under suitable conditions. The invention further relates to aVH libraries.

Abstract: A combustor includes a wall that defines a combustor interior to receive a fluid. The combustor also includes a slot that extends through the wall. The combustor also includes a resonator coupled to the wall. The resonator includes a resonator box defining a resonator interior between the wall and the resonator box, and a resonator segment disposed within the resonator box. The resonator segment includes a resonator neck having a resonator inlet and resonator outlet, the resonator inlet positioned within the resonator interior, the resonator outlet in flow communication with the combustor interior through the slot. The resonator neck defines a nonlinear flow path between the resonator inlet and the resonator outlet.

Abstract: The present invention relates to anti-HLA-G antibodies and methods of using the same.

Abstract: The present invention relates to multispecific antibodies that bind to HLA-G ant to a T cell activating antigen, their preparation, formulations and methods of using the same.

Abstract: The present invention relates to anti-HLA-G antibodies and methods of using the same.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The disclosure relates, inter alia, to a vehicle headlight (10), for example for a motor vehicle (1), wherein the vehicle headlight (10) comprises an illumination matrix (534) with a plurality of independently controllable illumination pixels for generating a (for example time-variant) illumination pattern, wherein the vehicle headlight (10) comprises an objective for imaging the illumination pattern, and wherein the objective comprises at least one objective lens.

Abstract: The present invention relates to anti-PD1 antibodies and methods of using the same.

Abstract: The present invention relates to anti-HLA-G antibodies and methods of using the same.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The disclosure relates, inter alia, to a vehicle headlight (10), for example for a motor vehicle (1), wherein the vehicle headlight (10) comprises an illumination matrix (534) with a plurality of independently controllable illumination pixels for generating a (for example time-variant) illumination pattern, wherein the vehicle headlight (10) comprises an objective for imaging the illumination pattern, and wherein the objective comprises at least one objective lens.

Abstract: The present invention relates to anti-LAG3 antibodies, to methods of producing these molecules and methods of using the same.

Abstract: Herein is reported a co-cultivation system for co-cultivating a pool of rabbit B-cells or single deposited rabbit B-cells wherein cells CD40L expressing CHO cells are used as feeder in the presence of TL-2 and TL-21.

Abstract: The invention provides anti-S-HBs antibodies and methods of using the same.

Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.

Abstract: The present invention relates to anti-PD1 antibodies and methods of using the same.

Abstract: The disclosure provides for cleaning three-dimensional (3D) components printed in a powder bed from adhering powder particles. The 3D-printed components are cleaned with a negative pressure-induced volumetric flow. The 3D-printed components are first removed from the powder bed after their manufacture, then positioned on a feed device and moved together with the feed device into a pressure-tight sealable chamber. In the interior of the chamber negative pressure is subsequently built up and a fluid volumetric flow is applied to the 3D-printed component to be cleaned which results in the powder particles being detached from the 3D-printed component. The powder particles are removed from the sealed chamber in a pressure tight manner via at least one channel conduit which is subjected to negative pressure and are fed to a separation device. The chamber is subsequently released of pressure and then opened for removal of the cleaned 3D-printed component.